Oshima, Masaya
Pechberty, Séverine
Bellini, Lara
Göpel, Sven O.
Campana, Mélanie
Rouch, Claude
Dairou, Julien
Cosentino, Cristina
Fantuzzi, Federica
Toivonen, Sanna
Marchetti, Piero
Magnan, Christophe
Cnop, Miriam
Le Stunff, Hervé
Scharfmann, Raphaël
Funding for this research was provided by:
ANR Betadiamark
Laboratoire d’Excellence consortium Revive
The Foundation Bettencourt Schueller
Innovative Medicines Initiative 2 Joint Undertaking Rhapsody (115881)
European Union’s Horizon 2020 research and innovation programme, EFPIA and the Swiss State Secretariat for Education‚ Research and Innovation (16.0097)
European Union’s Horizon 2020 research and innovation programme, project T2DSystems (667191)
Aviesan-AstraZeneca program
Article History
Received: 21 May 2019
Accepted: 14 October 2019
First Online: 3 December 2019
Duality of interest
: The authors declare that there is no duality of interest associated with this manuscript.